Comparison

BCL2L13 Antibody (C-term) Blocking Peptide

Item no. ABC-BP7878b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Banga,S., Proc. Natl. Acad. Sci. U.S.A. 104 (12), 5121-5126 (2007)Yi,P., FEBS Lett. 534 (1-3), 61-68 (2003)Kataoka,T., J. Biol. Chem. 276 (22), 19548-19554 (2001)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Bcl-2-like protein 13,Bcl2-L-13,Bcl-rambo,Protein Mil1,BCL2L13,MIL1
Similar products Bcl-rambo, BCL2L13, Bcl2-L-13, MIL1, Bcl-2-like protein 13, Protein Mil1
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP7878b was selected from the C-term region of human BCL2L13. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
BCL2L10 belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The protein may promote the activation of caspase-3 and apoptosis.
Gene Name
BCL2L13
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close